Advertisement

Trudeau Institute Company Profile

19:05 EDT 25th May 2013 | BioPortfolio

The Trudeau Institute is an independent, not-for-profit, biomedical research organization, whose scientific mission is to make breakthrough discoveries leading to improved human health. Trudeau immunologists are committed to making breakthrough research discoveries that will prevent and treat cancer, asthma, allergy, arthritis, colitis, multiple sclerosis, and infectious diseases, such as tuberculosis, influenza and sepsis. The Institute is supported by federal and state grants, and contributions from individuals, private foundations, and corporations.


News Articles [ 15 Associated News Articles listed on BioPortfolio]

Trudeau researchers identify unforeseen regulation of the anti-bacterial immune response

(Trudeau Institute) New research from the laboratory of Dr. Andrea Cooper at the Trudeau Institute, just published in the European Journal of Immunology, holds promise for the improved prevention and...

Trudeau Institute announces participation in study will advance newly discovered treatments for bacterial infections

(Trudeau Institute) The Trudeau Institute has announced it is the recipient of a sub-contract for a translational research grant from the National Institutes of Health. This award will help the Instit...

Trudeau Institute to receive sub-contract for translational research grant from NIH

The Trudeau Institute has announced it is the recipient of a sub-contract for a translational research grant from the National Institutes of Health.

Trudeau Institute study holds promise for improved prevention and treatment of bacterial infections

New research from the laboratory of Dr. Andrea Cooper at the Trudeau Institute, just published in the European Journal of Immunology, holds promise for the improved prevention and treatment of bacteri...

Trudeau Institute Awarded Grant to Investigate a New Approach to Treating Illnesses Caused by Weaponized and Antibiotic-Resistant Bacteria

Saranac Lake, New York (PRWEB) December 20, 2012 Trudeau Institute faculty member Stephen T. Smiley, Ph.D. , has been awarded a grant to evaluate new strategies for improving patient survival af...

New Research from the Trudeau Institute Holds Promise for Cancer Immunotherapy Treatments

New research from the Trudeau Institute laboratory of Dr. Edward L. Pearce (Washington University) has promising implications for improving a treatment for cancer known as cellula...

Trudeau Researchers Discover How Prior Flu Immunity Protects From Fatal Secondary Infections

Immunity can come from infections of any earlier strain of the flu virus or through vaccination Saranac Lake, New York (PRWEB) October 03, 2012 New research from the Trudeau Institute demonstrates th...

NIH awards $9 million grant to study aging and immunity to infections

The Trudeau Institute today announced that faculty member Laura Haynes, Ph.D., was awarded a grant from the National Institutes of Health (NIH) to study how aging impacts the immune system's response...

Drugs and Medications [0 Results]

None

PubMed Articles [ 8 Associated PubMed Articles listed on BioPortfolio]

A focus on RNA viruses.

Improving animal care.

An interview with Rose Bartiss, RLATG, Animal Quality Control Specialist, Mouse Production and Screening Services, Trudeau Institute, Saranac Lake, NY.

Bim dictates naive CD4 T cell lifespan and the development of age-associated functional defects.

With age, peripheral naive CD4 T cells become both longer lived and functionally impaired and they express reduced levels of Bim, a proapoptotic Bcl family member. In this study, we show that reduced...

TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.

Immunization with the Yersinia pestis F1 and LcrV proteins improves survival in mouse and non-human primate models of pneumonic plague. F1- and LcrV-specific antibodies contribute to protection, howev...

Type I Interferons Regulate Cytolytic Activity of Memory CD8(+) T Cells in the Lung Airways during Respiratory Virus Challenge.

Memory CD8(+) T cells in the lung airways provide protection from secondary respiratory virus challenge by limiting early viral replication. Here, we demonstrate that although airway-resident memory C...

Clinical Trials [0 Results]

None

Companies [ 1 Associated Companies listed on BioPortfolio]

Trudeau Institute

The Trudeau Institute is an independent, not-for-profit, biomedical research organization, whose scientific mission is to make breakthrough discoveries leading to improved human h...

More Information about "Trudeau Institute" on BioPortfolio

We have published hundreds of Trudeau Institute news stories on BioPortfolio along with dozens of Trudeau Institute Clinical Trials and PubMed Articles about Trudeau Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Trudeau Institute Companies in our database. You can also find out about relevant Trudeau Institute Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement